Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II trial of a 26-valent pneumococcal conjugate vaccine in participants aged 2 months and older
CTR20243111Phase 2Active
- Sponsor
- Zhifei Green Bamboo
- Start
- Aug 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 26-valent pneumococcal conjugate vaccine in pneumococcal disease, Pneumococcal pneumonia (PP), pneumococcal meningitis, otitis media, Bacteremia, sponsored by Zhifei Green Bamboo. Started Aug 2024; status: active.
02
Drugs
26-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal diseasePneumococcal pneumonia (PP)pneumococcal meningitisotitis mediaBacteremia
Beyond the preview
Go deeper on CTR20243111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243111.